{"id":"https://openalex.org/W3096940077","doi":"https://doi.org/10.1093/clinchem/hvaa157","title":"Commentary on A Case of Rapid Deterioration with Marked Hypergammaglobulinemia","display_name":"Commentary on A Case of Rapid Deterioration with Marked Hypergammaglobulinemia","publication_year":2020,"publication_date":"2020-07-15","ids":{"openalex":"https://openalex.org/W3096940077","doi":"https://doi.org/10.1093/clinchem/hvaa157","mag":"3096940077","pmid":"https://pubmed.ncbi.nlm.nih.gov/33141908"},"language":"en","primary_location":{"id":"doi:10.1093/clinchem/hvaa157","doi":"https://doi.org/10.1093/clinchem/hvaa157","is_oa":false,"landing_page_url":"https://doi.org/10.1093/clinchem/hvaa157","pdf_url":null,"source":{"id":"https://openalex.org/S139212996","display_name":"Clinical Chemistry","issn_l":"0009-9147","issn":["0009-9147","1530-8561"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320272","host_organization_name":"American Association for Clinical Chemistry","host_organization_lineage":["https://openalex.org/P4310320272"],"host_organization_lineage_names":["American Association for Clinical Chemistry"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Chemistry","raw_type":"journal-article"},"volume":null,"type":"editorial","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037251994","display_name":"Ashley M. Eckel","orcid":"https://orcid.org/0000-0002-2130-4965","observed_orcids":["https://orcid.org/0000-0002-2130-4965"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashley M Eckel","raw_affiliation_strings":["Department of Laboratory Medicine, University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Laboratory Medicine, University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103186489","display_name":"David Wu","orcid":"https://orcid.org/0000-0001-7729-5730","observed_orcids":["https://orcid.org/0000-0001-7729-5730"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David Wu","raw_affiliation_strings":["Department of Laboratory Medicine, University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Laboratory Medicine, University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5103186489"],"corresponding_institution_ids":["https://openalex.org/I201448701"],"apc_list":{"value":4636,"currency":"USD","value_usd":4636},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"66","issue":"11","first_page":"1379","last_page":"1380"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.6890000104904175,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.6890000104904175,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13314","display_name":"Lymphadenopathy Diagnosis and Analysis","score":0.17569999396800995,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":0.024000000208616257,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/idiopathic-multicentric-castleman-disease","display_name":"idiopathic multicentric Castleman disease","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hypergammaglobulinemia","display_name":"hypergammaglobulinemia","score":0.972000002861023},{"id":"https://openalex.org/keywords/polyclonal-gammopathy","display_name":"polyclonal gammopathy","score":0.9399999976158142},{"id":"https://openalex.org/keywords/lymphadenopathy","display_name":"lymphadenopathy","score":0.765999972820282},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.8830000162124634},{"id":"https://openalex.org/keywords/anti-il-6-monoclonal-antibody","display_name":"anti-IL-6 monoclonal antibody","score":0.875},{"id":"https://openalex.org/keywords/mtor-inhibition","display_name":"mTOR inhibition","score":0.8050000071525574},{"id":"https://openalex.org/keywords/systemic-inflammation","display_name":"systemic inflammation","score":0.3610000014305115}],"concepts":[{"id":"https://openalex.org/C2780514984","wikidata":"https://www.wikidata.org/wiki/Q17146775","display_name":"Hypergammaglobulinemia","level":3,"score":0.948177695274353},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4331490993499756},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.28326278924942017},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.11607256531715393}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006942","descriptor_name":"Hypergammaglobulinemia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D006942","descriptor_name":"Hypergammaglobulinemia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D010950","descriptor_name":"Plasma Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1093/clinchem/hvaa157","doi":"https://doi.org/10.1093/clinchem/hvaa157","is_oa":false,"landing_page_url":"https://doi.org/10.1093/clinchem/hvaa157","pdf_url":null,"source":{"id":"https://openalex.org/S139212996","display_name":"Clinical Chemistry","issn_l":"0009-9147","issn":["0009-9147","1530-8561"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320272","host_organization_name":"American Association for Clinical Chemistry","host_organization_lineage":["https://openalex.org/P4310320272"],"host_organization_lineage_names":["American Association for Clinical Chemistry"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Chemistry","raw_type":"journal-article"},{"id":"pmid:33141908","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33141908","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320330792","display_name":"EUSA Pharma","ror":"https://ror.org/01p7jrr32"},{"id":"https://openalex.org/F4320337601","display_name":"Janssen Pharmaceuticals","ror":"https://ror.org/03qd7mz70"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":2,"referenced_works":["https://openalex.org/W2902760866","https://openalex.org/W2968883182"],"related_works":["https://openalex.org/W4296526509","https://openalex.org/W4417521087","https://openalex.org/W4405127179","https://openalex.org/W4404091148","https://openalex.org/W3179397223","https://openalex.org/W7125798685","https://openalex.org/W1988543116","https://openalex.org/W4385377869","https://openalex.org/W2550406158","https://openalex.org/W4411004603"],"abstract_inverted_index":{"Leung":[0,236],"and":[1,20,39,42,64,75,116,118,126,151,156,159,191,260],"colleagues":[2],"describe":[3],"a":[4,8,54,69,76,149],"young":[5],"patient":[6,270],"with":[7,59,255],"marked":[9],"lymphadenopathy,":[10],"worsening":[11],"clinical":[12,66,130],"picture,":[13],"laboratory":[14,100,198,257],"tests":[15],"indicative":[16],"of":[17,132,165,196,216,249,263,283],"systemic":[18,77,109],"inflammation":[19],"polyclonal":[21],"gammopathy.":[22],"The":[23],"authors":[24],"exclude":[25],"numerous":[26,99],"differential":[27],"diagnoses":[28],"in":[29,88,98,105,209],"their":[30],"detailed":[31],"work-up":[32],"including":[33,68],"lymphoma,":[34],"viral":[35],"infections,":[36],"rheumatologic":[37],"conditions,":[38],"IgG4-related":[40],"disease":[41,48,51],"ultimately":[43],"diagnose":[44],"idiopathic":[45,81],"multicentric":[46,82],"Castleman":[47,50],"(iMCD).":[49],"(CD)":[52],"is":[53,124,148,178,185,193,205,224],"rare,":[55],"heterogeneous":[56],"hematologic":[57],"disorder":[58],"shared":[60],"lymph":[61,252],"node":[62,253],"histopathology":[63,164],"variable":[65],"presentation,":[67],"localized":[70],"variant":[71,78],"(unicentric":[72],"CD,":[73,83],"UCD)":[74],"known":[79],"as":[80,203,287],"iMCD":[84,91,133,189,246],"(1).":[85],"As":[86,233],"reported":[87],"this":[89,201],"patient,":[90],"can":[92,111,267],"cause":[93],"significant":[94],"physiologic":[95],"dysfunction":[96],"resulting":[97,142],"abnormalities":[101],"(Table":[102,239],"1).":[103],"Indeed,":[104],"some":[106,210,274],"patients,":[107],"these":[108,264],"complications":[110],"progress":[112],"to":[113,136,139,161,180,230,279],"end-organ":[114],"damage":[115],"failure":[117],"be":[119,137,277,292],"life-threatening.":[120],"Although":[121],"the":[122,129,162,197,213],"etiology":[123],"multifactorial":[125],"poorly":[127],"understood,":[128],"manifestations":[131],"are":[134],"thought":[135],"due":[138],"hypercytokinemia,":[140],"often":[141,206],"from":[143,171],"elevated":[144],"interleukin-6":[145],"(IL-6).":[146],"IL-6":[147,183,204,280],"growth":[150],"stimulatory":[152],"factor":[153],"for":[154,188,200,227,245],"B":[155],"plasma":[157],"cells,":[158],"contributes":[160],"characteristic":[163],"iMCD.":[166],"Some":[167],"patients":[168,275],"may":[169,276,291],"benefit":[170],"anti-IL-6":[172,231],"monoclonal":[173],"antibody":[174],"treatment.":[175],"However,":[176],"it":[177,192],"important":[179],"remember":[181],"that":[182],"elevation":[184],"not":[186,194,207,225],"specific":[187,226,256],"diagnosis,":[190,202],"one":[195],"criteria":[199],"increased":[208],"patients.":[211],"Further,":[212],"histolopathologic":[214],"subtype":[215],"iMCD,":[217],"(either":[218],"hypervascular,":[219],"plasmacytic":[220],"or":[221],"mixed":[222],"subtypes)":[223],"determining":[228],"responsiveness":[229],"inhibition.":[232],"reviewed":[234],"by":[235],"et":[237],"al.":[238],"2),":[240],"current":[241],"international":[242],"diagnostic":[243],"guidelines":[244],"require":[247],"identification":[248],"key":[250],"histopathologic":[251],"features":[254,265],"criteria.":[258],"Astute":[259],"timely":[261],"recognition":[262],"together":[266],"enable":[268],"prompt":[269],"care.":[271],"Importantly,":[272],"given":[273],"unresponsive":[278],"targeting,":[281],"consideration":[282],"alternate":[284],"treatments,":[285],"such":[286],"mTOR":[288],"pathway":[289],"inhibition,":[290],"potentially":[293],"beneficial":[294],"(2).":[295]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-11-09T00:00:00"}